$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
阿贝西利治疗HR+/HER2-转移性乳腺癌有着较好的疗效
2025-10-19 11:44:20
Check Details
阿贝西利可有效提高HR+/EHR2乳腺癌患者生存期
2025-10-19 11:44:20
Check Details
阿培利司的出现,使乳腺癌患者有了新选择!
2025-10-19 11:44:20
Check Details
患者使用阿培利司治疗乳腺癌时的注意事项
2025-10-19 11:44:20
Check Details
HR+/HER2-转移性乳腺癌克星药-阿贝西利
2025-10-19 11:44:20
Check Details
乳腺癌新药阿贝西利价格多少?哪里有售?
2025-10-19 11:44:20
Check Details
阿培利司在治疗晚期乳腺癌这方面有着显著的疗效
2025-10-19 11:44:20
Check Details
阿培利司对HR+/HER2的晚期或转移性乳腺癌有着不错的效果
2025-10-19 11:44:20
Check Details
乳腺癌新药阿培利司的安全性和有效性
2025-10-19 11:44:20
Check Details
PIK3抑制剂阿培利司对乳腺癌有多大的效果?
2025-10-19 11:44:20
Check Details
阿培利司可有效改善晚期乳腺癌患者的生存期
2025-10-19 11:44:20
Check Details
用甲氨蝶呤片治疗乳腺癌时需要注意的事项
2025-10-19 11:44:20
Check Details
1
2
...
1984
1985
1986
1987
1988
1989
1990
...
4153
4154
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
2
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
3
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
4
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
5
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
6
Complete Guide to Dosage and Dose Adjustment of Entrectinib
7
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
8
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
9
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
10
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
11
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
12
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer